Key Points
- Insider Robin Alfonso bought 768 CVS Group shares at an average price of GBX 1,294, for a total investment of approximately £9,938.
- CVS Group shares opened at GBX 1,297, with a market capitalization of about £897.5 million and a 12-month trading range of GBX 1,062 to GBX 1,648.
- Analysts maintain a “Moderate Buy” consensus, with four Buy ratings and one Hold rating and an average price target of GBX 1,720.
CVS Group plc (LON:CVSG - Get Free Report) insider Robin Alfonso acquired 768 shares of the business's stock in a transaction dated Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, for a total transaction of £9,937.92.
CVS Group Stock Performance
CVSG opened at GBX 1,297 on Friday. CVS Group plc has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. The firm has a market capitalization of £897.52 million, a PE ratio of 18.82, a P/E/G ratio of 1.77 and a beta of 1.06. The firm has a 50 day moving average of GBX 1,233.01 and a two-hundred day moving average of GBX 1,241.95.
CVS Group announced that its board has approved a share buyback plan on Tuesday, May 26th that allows the company to repurchase 0 outstanding shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on CVSG. Berenberg Bank reissued a "buy" rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, July 23rd. Jefferies Financial Group boosted their target price on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a "hold" rating in a research note on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of GBX 1,720.
View Our Latest Analysis on CVSG
CVS Group Company Profile
(
Get Free Report)
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
